אודות פרק זה
In this special awards-edition episode of Inside GRAPPA, host Fabian Proft sits down with GRAPPA Co-Presidents Professor Joseph F. Merola and Professor Arthur Kavanaugh. Together they reflect on their first encounters with the organization, the origins and evolution of GRAPPA, and the collaborative culture that continues to shape psoriatic disease research worldwide.
Joe and Artie share candid stories from the early days of TNF inhibitor trials, discuss the growing impact of Young GRAPPA, highlight the essential role of patient partners, and look ahead to the next five years of scientific and clinical progress in psoriatic disease.
- Joe and Artie share how they first became involved with GRAPPA and what drew them into psoriatic disease research.
- Artie reflects on GRAPPA’s early origins, shaped by global collaboration around the first TNF inhibitor studies.
- GRAPPA’s culture remains defined by openness, interdisciplinary exchange, and highly approachable leadership.
- Key unmet needs persist, including challenges in under-served psoriasis phenotypes and skin-to-joint progression.
- Personalized medicine in PsA is still an unmet priority, despite major therapeutic advances.
- GRAPPA’s future direction focuses on comorbidities, prevention, remission, and strengthening the next generation of leaders.
- 00:00 - Welcome & introduction
- 00:52 - Joe's first encounter with GRAPPA
- 01:56 - Artie describes GRAPPA's origins and early collaborations
- 03:26 - What makes GRAPPA's culture unique
- 05:26 - The role of patient partners
- 07:56 - Why Joe and Artie stepped into co-presidency
- 09:52 - Current unmet needs in psoriatic disease
- 11:16 - Personalized medicine and future clinical direction
- 12:18 - GRAPPA's next five years
- 13:16 - How clinicians, researchers, and trainees can get involved
Hosted on Acast. See acast.com/privacy for more information.
אנגלית
ארצות הברית
תעתיק 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
פרקים אחרים בפודקאסט הזה
What if we could predict psoriatic arthritis before it even begins? In this episode of Inside GRAPPA, host Dr. Hanna Johnsson is joined by Professors Oliver Fitzgerald and Steve Pennington to discuss the groundbreaking HIPPOCRATES Project. Funded by the Innovative Healthcare Initiative, this major…
In this episode of Inside GRAPPA, Dr. Joel Gelfand joins host Mio Nakamura to discuss a groundbreaking pragmatic trial that may transform access to phototherapy. A long-standing GRAPPA member and trailblazer in dermatologic research, Dr. Gelfand shares insights from the "LITE Study," a patient-cen…
How does multimorbidity impact the progression from psoriasis to psoriatic arthritis? Can early identification of chronic conditions help prevent psoriatic arthritis in high-risk patients?
In this episode of Inside GRAPPA, host Dr. Mio Nakamura sits down with Dr. Paras Karmacharya, recipient of a …
In this episode, host Dr. Fabian Proft explores the most impactful research and updates from the EADV 2024 Congress in Amsterdam. Joining him are distinguished Young GRAPPA members Dr. Dimitri Luz, Dr. Ahmet Uğur, and Dr. Margo Gkini, who each share their expert perspectives on groundbreaking stud…
How close are we to predicting psoriatic arthritis (PsA) before it strikes? In this episode of Inside GRAPPA, Dr. Fabian Proft sits down with two esteemed researchers, Dr. Axel Svedbom and Professor Mona Ståhle, from the Karolinska Institute in Stockholm, to discuss their groundbreaking study on p…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-GRAPPA Network, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
